-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Calidi Biotherapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from Q3 2021 to Q3 2025.
- Calidi Biotherapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $10K.
- Calidi Biotherapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $20K, a 150% increase year-over-year.
- Calidi Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $14K, a 12.5% decline from 2023.
- Calidi Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $16K, a 45.5% increase from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)